GSK stops development of chronic cough drug after late-stage trial miss - Reuters
GSK stops development of chronic cough drug after late-stage trial miss Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOOTJyXzZma0ZYNnRvRjM1c0kzLWg1eEVWSXdkNVRHTlFZR29CMzFReWlicTZiX0ZUOEdzbTB0UmM4VmlRMTdieHNHT2I5RjJPWHR3X0swbF9Ua0xLTXVfdmVCWDM4aE5mRkJHWTM3d1JOcjFxLWJsQjFVdHQtRHF0dTRud3Z4cXlyR25ZVWhkN2lGTEZrUVJJQ0FCZ0Q4SDU5SE1HcE1NTUdzaUtsQm1aWm5tVFA2SlNKU3hfSWw5R2N0SWlKSDQ0eVBxeTBMTXA3?oc=5" target="_blank">GSK stops development of chronic cough drug after late-stage trial miss</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters
August 17, 2026 at 03:45 PMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMUS FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PM